EpiVax Inc - Company Profile
Powered by
All the data and insights you need on EpiVax Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date EpiVax Inc Strategy Report
- Understand EpiVax Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on EpiVax Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4126901A4 | Search Report | Regulatorische t-zellen-epitope | A61K2035/122; A61K2039/55544; A61K2039/577; A61K35/17; A61K38/00; A61K39/0008; A61K39/001; A61K39/12; A61P37/00; C07K14/70503; C07K7/08; C12N2510/00; C12N2760/16034; C12N5/0637 | April 10, 2024 |
EP4076504A4 | Search Report | Modifiziertes interferon-alpha-2, das eine reduzierte immunogenität aufweist | A61K38/00; C07K14/56; C12N2740/16043; Y02A50/30 | April 10, 2024 |
US11911414B2 | Grant | Regulatory t cell epitopes | C12N5/0637; A61K2035/122; A61K35/17; C07K7/08 | February 27, 2024 |
AU2018346681B2 | Grant | Regulatory t cell epitopes | A61K38/00; A61P11/06; C07K14/52; C07K14/70539; C07K14/745; C07K2317/34; C07K2319/00; C12N5/0637 | February 22, 2024 |
US11844826B2 | Grant | Regulatory t cell epitopes, compositions and uses thereof | A61K38/00; A61K39/0008; A61P1/16; A61P11/00; A61P11/06; A61P13/12; A61P15/00; A61P15/08; A61P17/00; A61P17/02; A61P21/00; A61P21/04; A61P25/00; A61P25/08; A61P27/16; A61P29/00; A61P3/00; A61P3/10; A61P31/04; A61P31/10; A61P31/12; A61P31/18; A61P31/20; A61P33/00; A61P35/00; A61P35/02; A61P37/00; A61P37/02; A61P37/04; A61P37/06; A61P37/08; A61P43/00; A61P5/14; A61P7/00; A61P7/02; A61P7/04; A61P7/06; A61P9/00; C07K14/47; C07K14/75; C07K14/76; C07K14/78; C07K14/79 | December 19, 2023 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer